Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa

by Gonzalez, Franshesca , Krishnan, Suma , Agostini, Brittani , Guide, Shireen V. , Chen, Hubert , Gonzalez, Mercedes E. , Bağcı, I. Sinem , Chitra, Surya , Marinkovich, M. Peter , Kammerman, Lisa A. , Parry, Trevor J. , Quesada Sanchez, Lori , Steimer, Molly , Kapadia, Binoy , Feeney, Gloria , Van Ligten, Matthew , Sridhar, Kunju

in Administration, Topical / Age / Clinical trials / Collagen (type I) / Collagen Type VII - administration & dosage / Collagen Type VII - adverse effects / Collagen Type VII - genetics / Collagen Type VII - metabolism / Dermatology / Dermatology General / Design / Drug dosages / Dystrophic epidermolysis bullosa / Epidermolysis bullosa / Epidermolysis Bullosa Dystrophica - drug therapy / Epidermolysis Bullosa Dystrophica - genetics / Epidermolysis Bullosa Dystrophica - metabolism / FDA approval / Gene therapy / Genetic Therapy - adverse effects / Genetic Therapy - methods / Genetics / Genetics General / Herpes simplex / Herpes viruses / Humans / Pain / Patients / Pediatrics / Pediatrics General / Placebos / Pruritus / Pruritus - chemically induced / Questionnaires / Side effects / Skin / Skin diseases / Wound healing / Wound Healing - drug effects / Wound Healing - genetics

2022

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa

2022

Confirm

Do you wish to request the book?

Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa

2022

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa

Gonzalez, Franshesca,

Krishnan, Suma,

Agostini, Brittani,

Guide, Shireen V.,

Chen, Hubert,

Gonzalez, Mercedes E.,

Bağcı, I. Sinem,

Chitra, Surya,

Marinkovich, M. Peter,

Kammerman, Lisa A.,

Parry, Trevor J.,

Quesada Sanchez, Lori,

Steimer, Molly,

Kapadia, Binoy,

Feeney, Gloria,

Van Ligten, Matthew,

Sridhar, Kunju

2022

Overview

This genetic blistering disease is the result of mutations in COL7A1 , which encodes type VII collagen. Topical HSV-1 gene therapy delivering COL7A1 resulted in greater wound healing at 6 months than placebo.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

Administration, Topical

/ Age

/ Clinical trials

/ Collagen (type I)

/ Collagen Type VII - administration & dosage

/ Collagen Type VII - adverse effects

/ Collagen Type VII - genetics